Business · 30/09/2026Updated: 10/17/2026 · 1 min read

FDA Determines ISTURISA Tablets Were Not Withdrawn Due to Safety or Efficacy Concerns

Summary

The Food and Drug Administration has made a determination that ISTURISA tablets, 10 milligrams, were not withdrawn from sale due to concerns over safety or effectiveness, contrary to a previous notice

Original source language: Federal Register — Health and Human ServicesOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Business · 10/23/2026

Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of one additional draft chapter of a multichapter draft guidance for industry titled "Hazard Analysis and Risk-Based Preventive…

Read summary →

Business · 10/23/2026

Action Levels for Cadmium in Processed Food Intended for Babies and Young Children; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a draft guidance for industry entitled "Action Levels for Cadmium in Processed Food Intended for Babies and Young Children."…

Read summary →

Business · 10/23/2026

Supplemental Nutrition Assistance Program: Electronic Benefits Transfer Card Security Measures

The Food and Nutrition Administration (FNA or the Agency), an agency of the U.S. Department of Agriculture (USDA or the Department), is issuing a rule proposing changes to Supplemental Nutrition Assistance Program (SN…

Read summary →

Business · 10/23/2026

HHS Approval of Entities That Certify Medical Review Officers

This notice publishes a list of HHS approved Medical Review Officers (MROs) certification entities. The most recent HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), effectiv…

Read summary →

Business · 10/23/2026

Full-Life Technologies Reports Encouraging Preliminary Phase 1 Safety and PSA Decline for FL-020 in mCRPC at ESMO 2026

Data updates from the ongoing Phase 1 dose-escalation study demonstrated promising therapeutic index in patients with mCRPC No dose-limiting toxicities observed; xerostomia has been predominantly Grade 1, with no case…

Read summary →

Business · 10/23/2026

Tribal Advisory Committee; Notice of Solicitation for Nominations

Through this notice, the U.S. Department of Agriculture (USDA) is soliciting nominations for eight (8) vacancies on the USDA Tribal Advisory Committee ("the Committee").

Read summary →